Fanconi anemia (FA) is a rare genetic disorder impairing bone marrow's blood cell production, leading to severe health issues. Early diagnosis and tre ...

Swedish company Cantargia has enrolled the first patient in the Phase Ib/IIa trial of nadunolimab for treating individuals ...

Manjit Kooner's journey with Myelodysplastic Syndrome (MDS) has been a challenging one, marked by strength, resilience, and ...

TScan Therapeutics is developing TSC-101 and multiplex TCR-Ts for cancer treatment. See why TCRX stock holds potential with ...

Anaemia is defined as a reduction in haemoglobin levels, with thresholds of less than 12g/dL in women and less than 13g/dL in ...

Open label study in forty AML and MDS patients Study financed by the US Department of Defense Cantargia (Cantargia AB; Nasdaq ...

A steam locomotive, which has been restored in memory of a boy from Plymstock, has made its maiden voyage. The 'Lord Oliver ...

Keros Therapeutics' stock has plummeted over 70% due to safety issues in its phase 2 PAH study, halting all trial arms. Learn more about KROS stock here.

STATEN ISLAND, N.Y. — A fundraising Polar Plunge to honor John Hudson Dilgen will take place this month in South Beach to ...

Saeed Sadeghi, MD, discusses the findings on transfusion independence achieved with treatment for patients with low-risk myelodysplastic syndrome.

Equities researchers at StockNews.com initiated coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) ...

A doomsday prepper has gone viral for telling women how to prepare for attacks, emergencies and the apocalypse with a variety ...